Patents

US 12742792 B2: Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy

Granted
2026-09-22
Filed
2022-09-19 application 17947738
Type
Utility · 19 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Described herein are methods and systems for the determination of constituents in biosamples by NMR spectroscopy and more specifically for the determination of lipoprotein constituents LP-X, LP-Y, and LP-Z in blood plasma and serum.

Source: PTBLXML, file of 2026-09-22 (ipgb20260922.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Laboratory Corporation of America Holdings 128 patentsUS company or organizationBurlington, NCPTBLXML, file of 2026-09-22

Inventors

InventorPlacePatentsPerson pageSource
James D. OtvosApex, NCPTBLXML, file of 2026-09-22
Irina ShalaurovaCary, NCPTBLXML, file of 2026-09-22
Alan RemaleyBethesda, MDPTBLXML, file of 2026-09-22
Maureen SampsonSilver Spring, MDPTBLXML, file of 2026-09-22
Lita FreemanBethesda, MDPTBLXML, file of 2026-09-22

CPC categories

SubclassCategoryFirst groupSource
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N33/92PTBLXML, file of 2026-09-22

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.